Dorsal Root Ganglion Stimulation in Experimental Painful Diabetic Peripheral Neuropathy: Burst vs. Conventional Stimulation Paradigm.
Burst stimulation
dorsal root ganglion stimulation
mechanical hypersensitivity
neuropathic pain
painful diabetic peripheral neuropathy
Journal
Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
26
08
2018
revised:
26
10
2018
accepted:
12
11
2018
pubmed:
21
12
2018
medline:
2
6
2020
entrez:
21
12
2018
Statut:
ppublish
Résumé
Painful diabetic peripheral neuropathy (PDPN) is a long-term complication of diabetes mellitus (DM). Dorsal Root Ganglion Stimulation (DRGS) has recently emerged as a neuromodulation modality in the treatment of chronic neuropathic pain. The objective of this study was to compare the effect of burst DRGS (Burst-DRGS) and conventional DRGS (Con-DRGS) in an experimental model of PDPN. DM was induced in female Sprague-Dawley rats by intraperitoneal injection of streptozotocin (STZ, n = 48). Animals were tested for mechanical hypersensitivity (50% hind paw withdrawal threshold on Von Frey test) before, and 4 weeks after STZ injection. PDPN rats were then implanted with a unilateral bipolar lead at the L5 DRG (n = 22) and were stimulated for 30 min at days 2 and 3 postimplantation. Animals received Con-DRGS and Burst-DRGS in a randomized crossover design (n = 10), or received Sham-DRGS (n = 7) for 30 min, and were tested for mechanical hypersensitivity at baseline, 15 and 30 min during DRGS, and 15 and 30 min following DRGS. Five animals were withdrawn from the study due to electrode-related technical problems. Con-DRGS and Burst-DRGS normalized STZ-induced mechanical hypersensitivity at 15 and 30 min during stimulation. A significant difference in terms of mechanical hypersensitivity was observed between both of the stimulated groups and the Sham-DRGS group at 15 and 30 min during stimulation. Interestingly, Burst-DRGS showed signs of a residual effect at 15 min after cessation of stimulation, while this was not the case for Con-DRGS. Under the conditions tested, Con-DRGS and Burst-DRGS are equally effective in attenuating STZ-induced mechanical hypersensitivity in an animal model of PDPN. Burst-DRGS showed signs of a residual effect at 15 min after cessation of stimulation, which requires further investigation.
Identifiants
pubmed: 30570187
doi: 10.1111/ner.12908
pmc: PMC7027839
pii: S0002-8223(21)07031-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
943-950Subventions
Organisme : Abbott Laboratories
Organisme : Dorsal Root Ganglion Stimulation in neuropathic pain: Effect of stimulation settings and pain relief in an experimental model of painful diabetic polyneuropathy
Informations de copyright
© 2018 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society.
Références
Neuromodulation. 2018 Jan;21(1):19-30
pubmed: 29178358
Eur J Pain. 2017 Mar;21(3):507-519
pubmed: 27714945
Pain. 1997 Oct;73(1):87-95
pubmed: 9414060
Neurosurgery. 1996 Aug;39(2):367-74; discussion 374-5
pubmed: 8832675
Pain. 2017 Apr;158(4):669-681
pubmed: 28030470
Clin J Pain. 2015 May;31(5):433-7
pubmed: 24977394
J Clin Invest. 2017 May 1;127(5):1741-1756
pubmed: 28375159
Eur J Pain. 2017 May;21(5):795-803
pubmed: 27891705
Diabetes Care. 2011 Oct;34(10):2220-4
pubmed: 21852677
World Neurosurg. 2013 Nov;80(5):642-649.e1
pubmed: 23321375
Eur J Pain. 2004 Oct;8(5):397-411
pubmed: 15324772
Neuromodulation. 2013 Jul-Aug;16(4):304-11; discussion 310-1
pubmed: 23421796
Diabetes Care. 2015 Sep;38(9):e132-4
pubmed: 26116722
Eur J Pain. 2013 Oct;17(9):1338-46
pubmed: 23609991
Neuroimage. 2017 Feb 15;147:10-18
pubmed: 27876655
Neuromodulation. 2014 Feb;17(2):152-9
pubmed: 24655043
Ann Neurosci. 2011 Oct;18(4):168-75
pubmed: 25205950
Neuromodulation. 2015 Jan;18(1):24-32; discussion 32
pubmed: 25354206
Neuromodulation. 2014 Feb;17(2):143-51
pubmed: 24655042
Neuromodulation. 2015 Jan;18(1):1-8; discussion 8
pubmed: 25145400
Diabetes Care. 2006 Jul;29(7):1518-22
pubmed: 16801572
Neurosurgery. 2010 May;66(5):986-90
pubmed: 20404705
Neuromodulation. 2018 Dec;21(8):787-792
pubmed: 29575331
J Neurosci Methods. 1994 Jul;53(1):55-63
pubmed: 7990513
Diabetes Care. 2014 Nov;37(11):3016-24
pubmed: 25216508
Anesth Analg. 2016 Feb 8;122(4):1178-1185
pubmed: 26859873
Neuromodulation. 2016 Jun;19(4):373-84
pubmed: 27150431
MedGenMed. 2007 May 15;9(2):36
pubmed: 17955091
J Pain. 2012 Jun;13(6):519-23
pubmed: 22543045
J Pain. 2016 Dec;17(12):1349-1358
pubmed: 27687223
Neurochem Int. 2012 Jan;60(1):21-30
pubmed: 22107704
IEEE Trans Biomed Eng. 2015 Jun;62(6):1604-13
pubmed: 25667344
Diabet Med. 2004 Sep;21(9):976-82
pubmed: 15317601
Pain. 2014 Nov;155(11):2426-31
pubmed: 25180016
Neuromodulation. 2015 Jan;18(1):50-7; discussion 57
pubmed: 25147020
Neuromodulation. 2018 Jul;21(5):472-479
pubmed: 29522270
Pain Pract. 2018 Nov;18(8):988-996
pubmed: 29679457
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
Methods Mol Med. 2004;99:55-65
pubmed: 15131329